Measure Title: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF KETAMINE THERAPY TO TREAT DEPRESSION.
Report Title: Health; Medicaid; Insurance; Ketamine Therapy; Auditor; Report
Description:
Companion:  SR13
Package: None
Current Referral: CPN
Introducer(s): FEVELLA
Act:

Sort by Date Status Text
3/16/2023SThe committee(s) on CPN recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPN were as follows: 5 Aye(s): Senator(s) Keohokalole, Fukunaga, McKelvey, Richards, Awa; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
3/10/2023SThe committee(s) on CPN has scheduled a public hearing on 03-16-23 10:00AM; Conference Room 229 & Videoconference.
1/30/2023SReferred to CPN.
1/25/2023SOffered.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SCR15
All Versions of this Measure
Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.
Hearing Notices
CPN
3/16/23 10:00A
CR 229 & Videoconference